Glaukos Corporation vs Pfizer, Inc. — Stock Comparison

GKOS
Glaukos Corporation
$140.22
▼ 2.40%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.8/10

Q·Score Breakdown

5.8
Neutral
Overall
6.5
Neutral
1.1
Quality
7.4
9.2
Health
7
7.4
Growth
5.6
4.2
Valuation
6.7
8.9
Sentiment
5.2
GKOS

Clean balance sheet with low leverage (0.2× debt-to-equity).

currently unprofitable (-34% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $151.08 (+7.7%)
12 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

GKOS
PFE
Trailing P/E
19.4×
293.1×
Forward P/E
9.4×
-34.3%
Profit Margin
12.4%
78.1%
Gross Margin
75.8%
-26.4%
ROE
8.9%
41.2%
Revenue Growth
-1.2%
Earnings Growth
0.78
Beta
0.39
Price / Book
$8.2B
Market Cap
$149.8B
$73 – $147
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →